1. Аbulkasimov S.P., Pulatov Zh.А., Mukhamedov Kh. Kh., Saidoripov K.А. Outcomes of treatment with bedaquiline within comprehensive treatment of pulmonary tuberculosis patients with extensive drug resistance. Molodoy Ucheny, 2017, no. 5 (2), pp. 4-5. (In Russ.) Available: https://moluch.ru/archive/139/39857/
2. Budanov S.V. Adverse effects caused by fluoroquinolones in the clinical practice (results of adverse effects monitoring). Moskovskiy Khirurgicheskiy Journal, 2010, no. 3, pp. 17-19. (In Russ.)
3. Galeeva Zh.А., Zyryanov S.K. Cardiac toxicity of macrolide antibiotics. Klin. Microbiol. Antimicrob. Khimioter., 2015, vol. 17, no. 4, pp. 262-266. (In Russ.)
4. Zhukova E.M., Kolpakova T.А., Myshkova E.P., Reykhrud T.А. Experience of using bedaquiline and linezolid within comprehensive treatment of the pulmonary tuberculosis patient with extensive drug resistance of M. tuberculosis. Tuberculosis and Lung Diseases, 2016, vol. 94, no. 10, pp. 62-66. (In Russ.)
5. Model S.V., Kuzmina А.V., Galstyan G.M., Sokolov А.N., Troitskaya V.V. Management of ventricular tachycardia paroxysms of torsades-de-pointes in the female patient with the syndrome of extended electrical systole developed due to anti-bacterial therapy. Gematologiya i Transfuziologiya, 2015, vol. 60, no. 2, pp. 44-51. (In Russ.)